Pocket-Sized ECG could spot heart attacks in minutes

NCT ID NCT07715474

Ongoing Diagnosis Sponsor: HeartBeam, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a compact 3-lead ECG device can accurately detect acute coronary syndrome (heart attack) in adults arriving at the emergency department with chest pain. Participants receive a HeartBeam ECG recording within 10 minutes of the standard 12-lead ECG. The goal is to compare the device's sensitivity and specificity against the gold-standard diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HeartBeam 3-dimensional 3-lead ECG system
What this could lead to: If successful, this portable ECG could enable faster, more accessible heart attack detection in emergency settings.
What could go wrong: This is a small pilot study, so results may not confirm the device's accuracy. The system is for research only and not yet used for patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROMES

Contacts and locations

Show contact details

Locations

University Clinical Centre of Serbia

Belgrade, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.